Journal of Tissue Repair and Regeneration

Journal of Tissue Repair and Regeneration

Journal of Tissue Repair and Regeneration

Current Issue Volume No: 1 Issue No: 1

Research Article Open Access Available online freely Peer Reviewed Citation

Lysozyme-Induced Degradation of Chitosan: The Characterisation of Degraded Chitosan Scaffolds

Andrea Lončarević 1,   Marica Ivanković 1,   Anamarija Rogina 1  

1Faculty of Chemical Engineering and Technology, University of Zagreb

Abstract

Up till now, chitosan has confirmed its versatile application in skin, cartilage and bone tissue engineering, as well as in drug delivery applications. This study is focused on enzymatic degradation of porous chitosan structures usually designed for mentioned purposes. In vitro degradation was monitored during four weeks of incubation at physiological temperature and in two different media, phosphate buffer saline solution and water. The scaffolds were characterised before and after enzymatic degradation using scanning electron microscopy and infrared spectroscopy with Fourier transformations (FTIR). According to the gravimetric analysis, higher weight loss of chitosan scaffolds was observed in buffered medium with respect to the water. The results implied that the total weight loss obtained in buffer involves physical dissolution of chitosan and lysozyme cleavage of glycoside bond. Importantly, FTIR identification of chitosan scaffolds after enzymatic degradation indicated the absence of lysozyme activity in water, indicating that weight loss is a result of the chitosan dissolution. This finding greatly impacts design of degradation experiments and characterisation of degradation behaviour of chitosan-based materials utilised as implants or drug delivery systems.

Author Contributions
Received 25 Oct 2017; Accepted 20 Dec 2017; Published 26 Dec 2017;

Academic Editor: Lin Ye, Cardiff China Medical Research Collaborative, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK, Email: [email protected]

Checked for plagiarism: Yes

Review by: Single-blind

Copyright ©  2017 Andrea Lončarević, et al.

License
Creative Commons License     This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Competing interests

The authors have declared that no competing interests exist.

Citation:

Andrea Lončarević, Marica Ivanković, Anamarija Rogina (2017) Lysozyme-Induced Degradation of Chitosan: The Characterisation of Degraded Chitosan Scaffolds. Journal of Tissue Repair and Regeneration - 1(1):12-22. https://doi.org/10.14302/issn.2640-6403.jtrr-17-1840

Download as RIS, BibTeX, Text (Include abstract )

DOI 10.14302/issn.2640-6403.jtrr-17-1840

Introduction

One of the most important derivatives of chitin is chitosan, poly (D-glucosamine), a product of chitin deacetylation process. Chitosan is a linear polysaccharide, crystalline polymer insoluble at pH greater than 71. Chitosan has proven to be biodegradable, with antibacterial activity and hydrophilic, possessing functional groups (–OH and –NH2) for secondary bonds formation2. Moreover, chitosan possesses high biocompatibility, good miscibility with other polymers and good coating properties for bulk implants. Even during degradation, chitosan-oligomers are found to be bioactive. Besides, chitosan-oligomers can act as probiotics that positively change intestinal microflora balance, inhibit growth of harmful bacteria, promote good digestion and boost immune function3, 4. Chitosan is nontoxic and has been approved by FDA for would dressing application5.

In the pharmaceutical field, chitosan is used as a drug delivery system for oral, nasal, parenteral and transdermal applications, as well as implant for gene delivery. High chemical reactivity has also led to several chitosan-drug systems for treating tumours6, 7, 8. Moreover, it is used for encapsulation of living cells as an inner core of composite spheres9. In many cases, cross-linked chitosan membranes are used (mostly with glutaraldehyde and genipin)10, 11, 12.

Numerous studies are focused on the development of chitosan implants as porous materials for the treatment of tissue defects (including cartilage, skin and bones) or to accelerate the tissue regeneration. The tissue restoration is a complex process that involves the interactions between the cells, extracellular matrix components and signalling compounds. During the healing process, certain regulatory mechanisms associated with inflammation and immune responses are initiated. Biodegradable implants that accelerate tissue healing have to fulfil certain requirements such as biocompatibility, bioactivity, mechanical stability and appropriate biodegradability. Such implants have to degrade at a rate similar to new tissue formation. Moreover, mechanical stability of the implant integrated with newly-formed extracellular matrix should correspond to the mechanical performance of surrounding tissue.

The biodegradability of chitosan in living organisms depends on the degree of deacetylation and molecular weight. Chitosan can be degraded by enzymes that hydrolyse linkages between glucosamine–glucosamine, glucosamine–N-acetyl-glucosamine and N-acetyl-glucosamine–N-acetyl-glucosamine units. In human body, chitosan degrades due to the activity of lysozyme and bacterial enzymes present in the colon. Likewise, degradation of chitosan can be carried out by chitosanase, chitin deacetylase and β-N-acetylhexosaminidase13, 14. The wide pallet of chitosan properties makes it extensively studied in terms of physical, chemical and biological properties.

One of the important properties of chitosan-based material is in vitro and in vivo degradation behaviour. Numerous in vitro studies have investigated the influence of different incubation conditions, such as type of a buffer solution, the pH of incubation medium, type and concentration of enzyme, molecular weight, crystallinity and degree of deacetylation on degradation behaviour15, 16. Most commonly used techniques to characterise the degradation behaviour included gravimetric analysis, gel permeation chromatography, quantity of reducing sugar ends, microstructure imaging using electronic microscopy etc. The in vitro degradation studies can estimate the materials behaviour in vivo. However, due to the complexity of biological environment in the body, it is difficult to simulate them in vitro. Lysozyme has been found in various human body fluids including serum with concentration of 4 – 13 mg/L and tears with 100-fold higher concentration17. This implies that chitosan degradation behaviour strongly depends on the implantation site.

The purpose of this study was to investigate the influence of lysozyme on the degradation behaviour under different degradation conditions (phosphate buffer saline solution and water). The important results obtained by the FTIR identification technique indicated that lysozyme activity strongly depends on pH value of incubation medium which in the end determines the mechanism of chitosan weight loss.

Experimental Procedure

Materials

Chitosan (CHT) with deacetylation degree of 95 – 98 % and molecular weight, MW, of 100 000 – 300 000 g/mol was purchased from Across Organics (Belgium). Acetic acid (99.5 %) was purchased from Poch Gliwice (Poland), sodium hydroxide (NaOH) from Gram-Mol (Croatia), and ethanol (EtOH, 96 %) from Kefo (Slovenia). All chemicals were of analytical grade. Enzymatic degradation was performed with lysozyme (LZ, ≥ 90 % proteins, activity ≥ 40 000 U/mg, Sigma-Aldrich, Canada).

The molecular weight of chitosan was analysed using a gel permeation chromatographer at 35 °C using Waters Breeze GPC system with a 1525 Binary HPLC pump (Waters Corporation, Milford, MA) equipped with a 2414 refractive index detector and four serial columns (Ultra hydrogel 7.8 mm ID X 30 cm). The chitosan powder was dissolved in acetic buffer (0.5 mol/L CH3COOH/0.2 mol/L CH3COONa) with pH = 4.5 which was used as a mobile phase at a flow rate of 0.5 mL/min and 20 µL injection volume. The average molecular weight (Mw) of chitosan was determined to be 220 000.

Preparation of Chitosan Scaffold

The porous chitosan structures were obtained by thermally induced phase separation as described elsewhere18. Briefly, chitosan was dissolved in 0.36 % (w/w) acetic acid resulting in 1.2 % (w/v) chitosan solution. The solution was frozen in an aluminium mould at –22 °C over night. Then, frozen samples were immersed into neutralization medium consisting of 1 mol/L NaOH and EtOH (volume ratio 1:1) at –22 °C for 12 h. Afterwards, samples were immersed into EtOH at –22 °C for 12 h and dehydrated by immersion into ethanol at ambient temperature for next 24 h. Dehydrated samples were left to dry at atmospheric conditions.

Characterization of Chitosan Scaffold

The morphology of scaffolds was imaged using scanning electron microscope TESCAN Vega3SEM Easyprobe with electron beam energy of 10 keV. Previously to imaging, samples were sputtered with palladium/gold plasma for 120 s. The estimation of pore size distribution was determined on 280 pores measured on different chitosan samples.

The porosity of chitosan scaffolds (n = 3) was estimated using Archimedes principle performed in phosphate buffer saline solution (PBS, ρ = 1.0 g/mL) at ambient temperature. The open porosity (φ) of scaffold was calculated according to the following equation:

(1)

Vporeis calculated as the weight of absorbed solution (PBS) divided by the density of the buffer. The amount of water absorbed in the pores was corrected by the swelling of non-porous chitosan samples. The scaffold’s volume (Vscaffold) was calculated as the ratio of scaffolds weight and experimentally determined density of non-porous chitosan film (ρ = 1.97 g/mL).

The swelling capacity was evaluated by scaffold’s immersion in phosphate buffer saline solution (pH = 7.5) and distilled water (pH = 6.50). Previously to immersion, scaffolds (n = 3) were weighted to obtain initial weight and subsequently immersed for 24 h at ambient temperature. Swollen samples were carefully weighted. The capacity of scaffold to absorb water was calculated as a difference in weight before and after swelling with respect to the initial weight of the sample.

The mechanical performance of chitosan scaffold was evaluated in terms of compressive and tensile strength in wet state (PBS, pH = 7.5) at ambient temperature. The compressive test was performed on previously swollen cylindrically-shaped samples (n = 5, diameter of 8 mm) with mechanical instrument Seiko TMA/SS6000 (Seiko Instrument Inc., Japan) with deformation rate of 50 µm/min. The tensile test was carried out by the same instrument on previously swollen samples (n = 5, diameter of 8 mm, height between 1 and 2 mm) until 10% of deformation with deformation rate of 1000 µm/min. The compressive and tensile moduli were determined as a slope of the stress–strain curve.

The scaffolds identification was carried out by infrared spectroscopy with Fourier transformations (FTIR) with a diamond crystal (Bruker Vertex 70) at 20 °C, in the spectral range of 4000 – 400 cm-1 with 24 scans and 4 cm-1 resolution.

In vitro Degradation Test

The degradation of chitosan scaffolds (n = 3) was performed in two media: phosphate buffer saline solution (PBS, pH = 7.4) and distilled water containing 800 mg/L of lysozyme at 37 °C in an orbital shaker at 50 rpm. Enzymatic degradation was monitored during four weeks, while the lysozyme solution was refreshed every third day. At predetermined time (1, 2, 3 and 4 weeks) samples were removed from the medium, rinsed with distilled water and dried in the oven at 50 °C until constant mass. The samples were weighted before (m1) and after in vitro degradation (m2). The degradation degree (Δm) was determined as the weight loss with respect to the initial weight of the sample:

… (2)

As a control, samples were incubated at the same conditions without lysozyme. During the degradation, pH of medium was measured by Schott CG 842 using BlueLine 14 electrode with a precision of 0.01.

Statistical analysis

Statistical comparison of the data was performed using ANOVA one-way test. A p value <0.05 was considered to be statistically significant. All data are presented as a mean value corrected by standard deviation (mean ± SD).

Results

Scaffold’s Microstructure

The microstructure of prepared chitosan scaffolds was investigated by SEM imaging. The highly porous structure is clearly observable in Figure 1a. The honeycomb-like pores with good interconnectivity were founded on scaffold’s cross section, which is important parameter in development of artificial grafts. Such microstructure allows a non-hindered diffusion of nutrients, oxygen and metabolic waste through entire volume of scaffold. The estimation of pore size using electronic microscopy (Figure 1b) indicates macroporous material with the majority of pores ranging from 100 to 250 µm.

Figure 1.SEM micrograph a); and pore size distribution b) of the cross section of chitosan scaffold.
SEM micrograph a); and pore size distribution b) of the cross section of chitosan scaffold.

Scaffold’s Physical Properties

Figure 2 summarises physical properties of chitosan scaffolds in terms of open porosity, swelling and mechanical performances under compressive and tensile loading. The estimated porosity of 98.5 ± 0.2% confirms highly porous structure observed by SEM analysis. Such porous structure allows material to absorb large quantity of water, as confirmed by the swelling ratio determined in PBS and water. The values of swelling ratio of 29.4 and 36.5 for PBS and water, respectively, indicate the ability of chitosan scaffold to absorb 30 times greater amount of water with respect to its weight. Apart from scaffold’s porosity, this ability originates also from the chitosan hydrogen nature.

Figure 2.Physical properties of chitosan scaffolds in terms of porosity, swelling and mechanical performances. Significant difference (p<0.05) between the groups is designated with asterisk (*).
Physical properties of chitosan scaffolds in terms of porosity, swelling and mechanical performances. Significant difference (p<0.05) between the groups is designated with asterisk (*).

Chitosan has been extensively characterized by compressive and tensile test 19, 20, indicating its greater resistance when subjected to traction. In this study, previously swollen chitosan scaffolds were tested in wet state allowing elastic behaviour of chitosan. During swelling, chitosan spongy-like texture transforms to hydrocolloid with greater ability to deform. This is clearly visible from 40-fold difference of elastic modulus regarding to the one determined under compression.

Degradation Behaviour of the Scaffold

The effect of enzymatic degradation on microstructure of chitosan scaffolds was analysed by SEM. Morphology of the surface and cross section of chitosan scaffolds incubated four weeks in PBS and water containing lysozyme is given in Figure 3. According to the micrographs, significant difference in the material treated in LZ/PBS and LZ/H2O was not observed. However, CHT scaffold treated in LZ/PBS exhibit more irregular pore boundaries with signs of breakdown in the continuity of honey-comb like microstructure, with respect to the scaffold incubated in LZ/H2O. Moreover, sheet-like structure appeared on the surface of scaffold after 21 days in LZ/PBS, which has been previously reported by Qasim et al.21. After four weeks, the formation of large pores was evident on scaffolds incubated in both degradation media with greater pore roughness and discontinuity with respect to the initial scaffold.

Figure 3.Microstructure of chitosan cross section (left) and surface (right) after four weeks of incubation in different lysozyme solutions.
Microstructure of chitosan cross section (left) and surface (right) after four weeks of incubation in different lysozyme solutions.

To support observations provided by electron microscopy, we investigated the degradation behaviour using gravimetric method. According to the literature1, the weight loss of porous chitosan depends on the initial concentration of chitosan solution, degree of deacetylation, distribution of molecular weight and swelling properties. Since we investigated chitosan materials with very high deacetylation degree (95 – 98%), it is no surprise to obtain lower weight loss due to the low sensitivity of amine groups to lysozyme. The degradation degree (Δm) of chitosan scaffolds incubated in LZ/PBS and LZ/H2O is depicted in Figure 4. The weight loss of chitosan scaffold (Figure 4a) exhibit the highest value of 17.3 ± 0.8 % after four weeks of incubation in LZ/PBS. On the other hand, weight loss resulted from the LZ/H2O incubation (Figure 4b), shows maximum value of 13.0 ± 1.9 % after first week, which is higher than scaffold incubated in LZ/PBS at the same time point (8.3 ± 1.2 %). The control samples incubated in PBS and H2O without lysozyme showed a similar trend of losing weight with approximately seven percent of total loss after first week, which remains constant during degradation study.

Figure 4.Degradation ratio of chitosan scaffolds performed in phosphate buffer saline solution a) and water b); the pH of incubation medium during degradation c).
Degradation ratio of chitosan scaffolds performed in phosphate buffer saline solution a) and water b); the pH of incubation medium during degradation c).

To gather more insight into degradation behaviour, we monitored the pH of incubation media (Figure 4c). The buffered-medium (LZ/PBS and PBS) did not show any changes during total incubation period; however, there are certain oscillations in water with and without lysozyme (LZ/H2O and H2O). Initial pH value of the aqueous solution with lysozyme is 3.7, which is lower than pK of chitosan (6.5). After first week of degradation, initial pH of LZ/H2O has increased and maintained over pH of 4. This could be a consequence of chitosan dissolution behaviour. Being polycation, chitosan is soluble in acid environment where functional amine (–NH2) groups neutralise the hydrogen ion (–NH3+) originated from the dissociation of the acid. In this way, chitosan acts as base increasing the pH value. Significant increase in pH of LZ/H2O during four weeks of incubation with respect to the initial solution can indicate that dissolution of chitosan scaffold was maintained by bi-weekly refreshment of lysozyme solution. The alternate change in pH of LZ/H2O supernatant could be a result of gradual dissolution of chitosan which is indicated by the weight loss. Such behaviour can originate from broad distribution of molecular weight (100 000 – 300 000) and of pore size (100 – 250 µm). In contrast to the LZ/H2O medium, water control medium exhibited higher pH with no significant difference in weight loss after first week indicating lower chitosan dissolution.

The strange degradation behaviour of chitosan scaffolds in lysozyme containing water medium has led us to identify the organic compounds of degraded-chitosan samples. Figure 5 represents FTIR spectra of initial chitosan scaffolds, lysozyme and scaffolds degraded in LZ/PBS and LZ/H2O after 4 weeks of incubation.

Figure 5.FTIR spectra of initial chitosan scaffold (CHT), lysozyme powder (LZ) and chitosan scaffolds during four weeks of incubation in phosphate buffer saline solution (PBS) and water with or without lysozyme.
FTIR spectra of initial chitosan scaffold (CHT), lysozyme powder (LZ) and chitosan scaffolds during four weeks of incubation in phosphate buffer saline solution (PBS) and water with or without lysozyme.

The characteristic absorption bands of chitosan corresponds to the stretching of the carbonyl group (amide I) and −NH bending (amide II) at 1644 cm-1 and 1583 cm-1, respectively, whose intensity depends on the deacetylation degree. The sharpness of the band at 1583 cm-1 confirms high deacetylation degree of chitosan. The absorption band in the range of 3359 − 3290 cm-1 is assigned to the overlapping of stretching vibration of amine (–NH2) and hydroxyl (–OH) groups. The absorption bands at 2917 cm-1 and 2869 cm-1 are associated with symmetric and asymmetric stretching of –CH, –CH2OH and –CH3 groups of the saccharide ring. The bands at 1420 cm-1 and 1374 cm-1 belong to the C−N and –CH3 bond of the acetyl group. Three stretching –CO groups are founded at range of wave numbers of 1151 – 1028 cm-1: the band at 1151 cm-1 is attributed to the asymmetric stretching of the oxygen atom from the bridge and carbon atom from the ring, while the bands from 1063 cm-1 to 1028 cm-1 are associated with –COH, –COC and –CH2OH22, 23. The FTIR spectrum of lysozyme exhibits characteristic amide bands at 1640 cm-1 (C=O; amide I) and 1525 cm-1 (–NH2; amide II) of polypeptide chain24.

The FTIR analysis of chitosan scaffolds degraded in LZ/PBS medium (CHT-LZ/PBS) showed the presence of amide absorption band of lysozyme which can indicate its remained deposition, compared to the control samples incubated in PBS. Even though the degraded samples were extensively washed with distilled water, the characteristic absorption band of lysozyme confirms strong electrostatic interactions between chitosan and lysozyme, which are necessary for glycoside bond cleavage. Interestingly, scaffolds that were subjected to the enzymatic degradation in water (CHT-LZ/H2O) show no difference in the FTIR spectrum with respect to the control scaffolds (CHT- H2O) indicating the lack of lysozyme activity in the pH range of 4 – 5, and chitosan dissolution process as a mechanism of scaffold’s weight loss.

Discussion

Chitosan is one of widely studied implantable materials for regenerative medicine and tissue engineering, mostly for wound and bone tissue restoration25, 26, 27. Among important requirements (biocompatibility, non-immunogenic properties, high porosity, and resistance to different mechanical forces) artificial graft has to be biodegradable with degradation rate that follows the rate of new tissue formation28. The degradation process is dictated by the mechanism of molecule cleavage into smaller ones and finally into molecules degradable by the biological processes. Accordingly, the degradation rate depends on materials properties such as the nature and composition, crystallinity and molecular weight, porosity, the pH of environment and implantation site. The insight into materials behaviour under physiological conditions will guide the design and development of potential tissue substituent or drug delivery system in terms of porosity, mechanical stability, surface modification, the release rate of active substance etc.

In this study, we investigated the degradation behaviour of chitosan scaffolds commonly used in tissue engineering. The main objective was to elucidate how medium conditions, supported by lysozyme presence, influence the chitosan biodegradation. Since prepared chitosan scaffolds are highly porous with good pore interconnectivity, the enzyme transport and diffusion of degradation products from material is facilitated, which is essential for tissue restoration. During enzymatic degradation, an enzyme first diffuses from the surrounding solution to the surface of the material. The subsequent adsorption leads to the formation of the enzyme-material complex. Then, enzyme starts the catalysis reaction of macromolecule cleavage causing the release of degradation products into the solution29, 30. A two-stage degradation of chitosan scaffolds with greater weight loss was observed in LZ/PBS medium. Low degradation degree of prepared chitosan is associated with very low quantity of acetyl group which are responsible for lysozomal binding20. The weight loss of chitosan scaffolds is generated by both, the lysozyme activity and chitosan dissolution. It is well known that chitosan dissolves when pH is lower than 6.5. However, the dissolution properties depend on molecular weight and MW distribution which is wide for chitosan used in this study. Therefore, chitosan dissolution could be possible even at neutral pH.

On contrary, the absence of significant difference in chitosan weight loss obtained from the LZ/H2O and H2O incubation can be related to the lysozyme inactivity. According to the manufacturer’s data sheet, lysozyme activity depends on the pH of dissolving medium, i.e. it is active at pH from 6.0 to 9.0. As shown from pH measurements, initial pH of LZ/H2O solution was far from the lysozyme activation conditions which solely resulted in dissolution process. This assumption was also confirmed by FTIR identification. As aforementioned, specific interactions between chitosan and lysozyme have to be provided to cleave the glycoside bond of chitosan. The absence of adsorbed lysozyme on scaffolds incubated in LZ/H2O medium confirms its inactivity. The chitosan weight loss in water containing lysozyme was not provided by the chemical reactions occurring during in vitro degradation. However, Han et al.13 studied the lysozyme degradation in acetate buffer (pH = 4.5) obtaining higher degradation and reduction of sugar ends regarding the phosphate buffered lysozyme solution and other buffered solution with pH of 4.5. Those results are in conflict with the fact that chitosan forms a chitosan-acetate buffer solution at pH of 4.5 – 4.8. Unfortunately, the mentioned study lacks information of lysozyme activity and identification of organic components of degraded samples.

The versatile application of chitosan-based materials in biomedical and pharmaceutical sciences imposes careful choosing of chitosan molecular weight, deacetylation degree and crystallinity that dictates in vitro and in vivo degradation. The identification of in vitro biodegraded chitosan materials represents great importance for designing and development of artificial grafts and drug delivery systems. Additionally, special attention should be given to degradation parameters such as pH of the medium and behaviour of applied enzyme. Moreover, we showed that most commonly used treatment of washing after scaffolds degradation is not adequate for determination of weight loss by gravimetric method due to strong interactions of lyosozyme active sites and N-acetlyglucosamine units of chitosan.

Degradation behaviour of potential tissue substituent or drug delivery system plays a role in treating the tumour-tissues. The pH of solid tumours is acidic due to increased fermentative metabolism which makes the adjacent normal tissue also acidic, leading to tumour invasion31. Chitosan-based nanoparticles showed their potential as drug-delivery carriers for cancer therapy due to the improvement of pharmacological and therapeutic properties of anti-cancer drugs controlling their release rate32. Since the peritumoral pH is heterogeneous, its direct monitoring near the treated surface in vivo could elucidate the microenvironmental conditions by pH microelectrodes33. The findings brought up by this study could help to determine if the rate of drug release and implant weight loss in similar applications is governed by the chitosan dissolution or biodegradation process.

Conclusions

The chitosan-based materials show promising potential in biomedical and pharmaceutical applications which requires suitable characterisation depending on the specific application. The degradation studies of chitosan scaffolds indicated limited activity of lysozyme which depends on the pH of incubation medium. According to the gravimetric analysis and FTIR identification, in vitro enzymatic degradation performed in phosphate buffer saline solution is dictated by physical (dissolution) and chemical (cleavage of glycoside bonds) processes, while lysozyme containing water medium causes only dissolution of chitosan. So far, such confirmation of enzyme inactivity has not yet been observed.

Acknowledgments

The Croatian Science Foundation under the project IP-2014-09-3752 is gratefully acknowledged. The authors want to thank Prof. G. Gallego Ferrer from Centre of Biomaterials and Tissue Engineering, Polytechnic University of Valencia, Spain for helping with compressive and tensile test.

References

  1. 1.Yang B, Li X, Shi S, Kong X, Guo G. (2010) . , Carbohydrate Polymers 80, 860-865.
  1. 2.Rinaudo M. (2006) . Progress in Polymer Science 31 603-632.
  1. 3.Wiśniewska-Wrona M, Niekraszewicz A, Ciechańska D, Pospieszny H, Orlikowski L B. (2007) . , Polish Chitin Society 12, 149-156.
  1. 4.Muzzarelli RAA. (2009) . , Carbohydrate Polymers 76, 167-182.
  1. 5.Wedmore I, J G McManus, Pusateri A E, Holcomb J B. (2006) . , The Journal of Trauma, Injury, Infection, and Critical Care 3, 655-658.
  1. 6.Nair L S, Laurencin C T. (2007) . Progress in Polymer Science 32 762-798.
  1. 7.Costa-Pinto A, Reis R, R L, Neves N M. (2011) . , Tissue engineering 5, 17.
  1. 8.Kean T, Thanou M. (2010) . , Advanced Drug Delivery Reviews 62, 11.
  1. 9.Zhu J-H, Wang X-W, Ng S, Quek C-H, Ho H-T. (2005) . , Journal of Biotechnology 117, 355-365.
  1. 10.Li Q, Dunn E T, Grandmaison E W, Goosen MFA. (1992) . , Journal of Bioactive and Compatible Polymers 7, 370-397.
  1. 11.Beppu M, Vieira M, R S, Aimoli C G, Santana C C. (2007) . , Journal of Membrane Science 301, 126-130.
  1. 12.Muzzarelli RAA. (2009) . , Carbohydrate Polymers 77, 1-9.
  1. 13.Han T, Nwe N, Furuike T, Tokura S, Tamura H. (2012) . , Journal Biomedical Science and Engineering 5, 15-23.
  1. 14.Onishi H, Machida Y. (1999) . , Biomaterials 20, 175-182.
  1. 15.Martínez A, Blanco M, Davidenko D, Cameron N, RE. (2015) . Carbohydrate Polymers 132, 606 – 619.
  1. 16.Yao Q, Li W, Yu S, Ma L, Jin D. (2015) . , Materials Science and Engineering C 56, 473-480.
  1. 17.Ren D, Yi H, Wang W, Ma X. (2005) . , Carbohydrate Research 340, 2403.
  1. 18.Rogina A, Rico P, Ferrer Gallego, Ivanković G, Ivanković M et al. (2015) . , European Polymer Journal 68, 278-287.
  1. 19.Albanna M Z, Bou-Akl T H, IIIHL Walters, Matthew HWT. (2012) . , Journal of Mechanical Behavior of Biomedical Materials 5, 171-180.
  1. 20.Huang Y, Onyeri S, Siewe M, Moshfeghian A, Madihally S V. (2005) . , Biomaterials 26, 7616-7627.
  1. 21.Qasim S B, Husain S, Huang Y, Pogorielov M, Deineka V et al. (2017) . Polymer Degradation and Stability 136 31-38.
  1. 22.Duarte M L, Ferreira M C, Marvão M R, Rocha J. (2002) . , International Journal of Biological Macromolecules 31, 1-8.
  1. 23.Perez C, Griebenow K. (2000) . , Biotechnology Letters 22, 1899-1905.
  1. 24.Sowjanya J, Singh A, Mohita J, Sarvanan T, Moorthi S et al. (2013) . Colloids and Surfaces B: Biointerfaces 109 294-300.
  1. 25.Nath S, Abueva D, Kim C, Lee B, BT. (2015) . , Carbohydrate Polymers 115, 160-169.
  1. 26.Jiang T, Nukavarapu S P, Deng M, Jabbarzadeh E, Kofron. (2010) . , Acta Biomaterialia 6, 3457-3470.
  1. 27.O’Brien F J. (2011) . , Materials Today 14, 88-95.
  1. 28.Chan B P, Leong K W. (2008) . , European Spine Journal 17, 467-479.
  1. 29.Banerjee A, Chatterjee K, Madras G. (2014) . Materials Sciences and Technology 5 567-573.
  1. 30.Azevedo H S, Reis R L. (2005) Understanding the enzymatic degradation of biodegradable polymers and strategies to control their degradation rate, in:. Biodegradable Systems in Tissue Engineering and Regenerative Medicine, CRC Press 12 , USA .
  1. 31.Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell H H et al. (2013) . , Cancer Research 73(5), 1524-1535.
  1. 32.Prabaharan M. (2015) . , International Journal of Biological Macromolecules 72, 1313-1322.
  1. 33.Liu W, Wang T, Yang C, Darvell B W, Wu J et al.. , Osteoporosis International doi:, 10-1007.

Cited by (53)

  1. 1.Joshi Prutha, Uddin Ahmed Md Shakir, Vig Komal, Auad Maria L., 2022, Formulation of the Polymeric Double Networks (DNs) for Biomedical Applications with Physicochemical Properties to Resemble a Biological Tissue, Sustainable Chemistry, 3(2), 248, 10.3390/suschem3020016
  1. 2.Kouser Sabia, Sheik Sareen, Prabhu Ashwini, Nagaraja G.K., Prashantha Kalappa, et al, 2021, Effects of reinforcement of sodium alginate functionalized halloysite clay nanotubes on thermo-mechanical properties and biocompatibility of poly (vinyl alcohol) nanocomposites, Journal of the Mechanical Behavior of Biomedical Materials, 118(), 104441, 10.1016/j.jmbbm.2021.104441
0094-243X XIAMEN-CUSTIPEN WORKSHOP ON THE EQUATION OF STATE OF DENSE NEUTRON-RICH MATTER IN THE ERA OF GRAVITATIONAL WAVE ASTRONOMY XIAMEN-CUSTIPEN WORKSHOP ON THE EQUATION OF STATE OF DENSE NEUTRON-RICH MATTER IN THE ERA OF GRAVITATIONAL WAVE ASTRONOMY Enzymatic degradation of chitosan blend for tissue engineering application Ashraq A. Kadhm Zuhair J. Abd Alameer Aseel B. Al. Zubaidi 2127 020017 10.1063/1.5116944 2019
  1. 4.Mantooth Siena M, Hancock Asher M, Thompson Peter M, Varghese P J George, Meritet Danielle M, et al, 2024, Characterization of an Injectable Chitosan Hydrogel for the Tunable, Localized Delivery of Immunotherapeutics, ACS Biomaterials Science & Engineering, 10(2), 905, 10.1021/acsbiomaterials.3c01580
  1. 5.Ahmad Ruzaidi Dania Adila, Mahat Mohd Muzamir, Mohamed Sofian Zarif, Nor Hashim Nikman Adli, Osman Hazwanee, et al, 2021, Synthesis and Characterization of Porous, Electro-Conductive Chitosan–Gelatin–Agar-Based PEDOT: PSS Scaffolds for Potential Use in Tissue Engineering, Polymers, 13(17), 2901, 10.3390/polym13172901
  1. 6.Shrestha Sita, Shrestha Bishnu Kumar, Ko Sung Won, Kandel Rupesh, Park Chan Hee, et al, 2021, Engineered cellular microenvironments from functionalized multiwalled carbon nanotubes integrating Zein/Chitosan @Polyurethane for bone cell regeneration, Carbohydrate Polymers, 251(), 117035, 10.1016/j.carbpol.2020.117035
  1. 7.Tabassum Nishat, Ahmed Shoeb, Ali M. Azam, 2021, Chitooligosaccharides and their structural-functional effect on hydrogels: A review, Carbohydrate Polymers, 261(), 117882, 10.1016/j.carbpol.2021.117882
  1. 8.Ambrosone Alfredo, Matteis Laura De, Serrano-Sevilla Inés, Tortiglione Claudia, De La Fuente Jesús M., 2020, Glycogen Synthase Kinase 3β Inhibitor Delivered by Chitosan Nanocapsules Promotes Safe, Fast, and Efficient Activation of Wnt Signaling In Vivo, ACS Biomaterials Science & Engineering, 6(5), 2893, 10.1021/acsbiomaterials.9b01820
  1. 9.Agarwal Priyanka, Rupenthal Ilva D., 2023, Non-aqueous formulations in topical ocular drug delivery – A paradigm shift?, Advanced Drug Delivery Reviews, 198(), 114867, 10.1016/j.addr.2023.114867
  1. 10.Patra Sukanya, Singh Monika, Pareek Divya, Wasnik Kirti, Gupta Prem S., et al, 2022, , , (), 532, 10.1016/B978-0-12-820352-1.00129-2
  1. 11.Li Ya, Wang Xiaonan, Han Yuanyuan, Sun Hung-Yu, Hilborn Jöns, et al, 2021, Click chemistry-based biopolymeric hydrogels for regenerative medicine, Biomedical Materials, 16(2), 022003, 10.1088/1748-605X/abc0b3
  1. 12.Than‐ardna Bhumin, Tamura Hiroshi, Furuike Tetsuya, 2022, Preparation, Characterization, and Properties of Chitosan‐Based Semi‐Interpenetrating Polymer Networks and Poly(2‐hydroxyethyl methacrylate) Structure, Macromolecular Chemistry and Physics, 223(24), 10.1002/macp.202200282
  1. 13.de Castro Raquel, Kandhola Gurshagan, Kim Jin-Woo, Moore Quincy C., Thompson Audie K., 2023, Fabrication of Chitosan/PEGDA Bionanocomposites for Enhanced Drug Encapsulation and Release Efficiency, Molecular Pharmaceutics, 20(11), 5532, 10.1021/acs.molpharmaceut.3c00415
  1. 14.Roman Diana Larisa, Ostafe Vasile, Isvoran Adriana, 2020, Deeper inside the specificity of lysozyme when degrading chitosan. A structural bioinformatics study, Journal of Molecular Graphics and Modelling, 100(), 107676, 10.1016/j.jmgm.2020.107676
  1. 15.Amariei Georgiana, Kokol Vanja, Boltes Karina, Letón Pedro, Rosal Roberto, 2018, Incorporation of antimicrobial peptides on electrospun nanofibres for biomedical applications, RSC Advances, 8(49), 28013, 10.1039/C8RA03861A
  1. 16.Rathinam Karthik, Singh Swatantra Pratap, Arnusch Christopher J., Kasher Roni, 2018, An environmentally-friendly chitosan-lysozyme biocomposite for the effective removal of dyes and heavy metals from aqueous solutions, Carbohydrate Polymers, 199(), 506, 10.1016/j.carbpol.2018.07.055
  1. 17.Nájera-Romero Griselda V., Yar Muhammad, Rehman Ihtesham Ur, 2020, Heparinized chitosan/hydroxyapatite scaffolds stimulate angiogenesis, Functional Composite Materials, 1(1), 10.1186/s42252-020-00012-y
  1. 18.Kim Jie Young, Kim Su Hee, Choi Min‐Ha, Lee Soo Hee, Cha Misun, et al, 2022, Novel Chitosan Dermal Filler with Enhanced Moldability and Elasticity, Macromolecular Bioscience, 22(8), 10.1002/mabi.202200081
  1. 19.Ayón Mirian A. González, Hoppenstedt Alejandro Mena, López Arturo Zizumbo, Sarabia Johanna Bernaldez, Claverie Angel Licea, et al, 2024, Semi‐Interpenetrated Polymer Networks Based on PHEMA and Modified Chitosan as a Potential Bactericide Hydrogel for Wound‐Healing, Macromolecular Chemistry and Physics, (), 10.1002/macp.202400018
  1. 20.Liu Jennifer S., Madruga Liszt Y. C., Yuan Yang, Kipper Matt J., Khetani Salman R., 2023, Decellularized Liver Nanofibers Enhance and Stabilize the Long‐Term Functions of Primary Human Hepatocytes In Vitro, Advanced Healthcare Materials, 12(19), 10.1002/adhm.202202302
  1. 21.Pádua Ana Sofia, Figueiredo Lígia, Silva Jorge Carvalho, Borges João Paulo, 2023, Chitosan scaffolds with mesoporous hydroxyapatite and mesoporous bioactive glass, Progress in Biomaterials, 12(2), 137, 10.1007/s40204-023-00217-x
  1. 22.Vo Nga T. N., Huang Lei, Lemos Henrique, Mellor Andrew L., Novakovic Katarina, 2021, Genipin‐crosslinked chitosan hydrogels: Preliminary evaluation of the in vitro biocompatibility and biodegradation, Journal of Applied Polymer Science, 138(34), 10.1002/app.50848
  1. 23.Ferreira Carolina A. M., Januário Adriana P., Félix Rafael, Alves Nuno, Lemos Marco F. L., et al, 2021, Multifunctional Gelatin/Chitosan Electrospun Wound Dressing Dopped with Undaria pinnatifida Phlorotannin-Enriched Extract for Skin Regeneration, Pharmaceutics, 13(12), 2152, 10.3390/pharmaceutics13122152
  1. 24.Maiz-Fernández Sheila, Guaresti Olatz, Pérez-Álvarez Leyre, Ruiz-Rubio Leire, Gabilondo Nagore, et al, 2020, β-Glycerol phosphate/genipin chitosan hydrogels: A comparative study of their properties and diclofenac delivery, Carbohydrate Polymers, 248(), 116811, 10.1016/j.carbpol.2020.116811
  1. 25.Palomino-Durand Carla, Lopez Marco, Marchandise Pierre, Martel Bernard, Blanchemain Nicolas, et al, 2020, Chitosan/Polycyclodextrin (CHT/PCD)-Based Sponges Delivering VEGF to Enhance Angiogenesis for Bone Regeneration, Pharmaceutics, 12(9), 784, 10.3390/pharmaceutics12090784
  1. 26.Sharmila Govindasamy, Muthukumaran Chandrasekaran, Kirthika Shanmugam, Keerthana Sundarapandian, Kumar Narasimhan Manoj, et al, 2020, Fabrication and characterization of Spinacia oleracea extract incorporated alginate/carboxymethyl cellulose microporous scaffold for bone tissue engineering, International Journal of Biological Macromolecules, 156(), 430, 10.1016/j.ijbiomac.2020.04.059
  1. 27.Baek Jiyoo, Ramasamy Mohankandhasamy, Willis Natasha Carly, Kim Dae Sung, Anderson William A., et al, 2021, Encapsulation and controlled release of vitamin C in modified cellulose nanocrystal/chitosan nanocapsules, Current Research in Food Science, 4(), 215, 10.1016/j.crfs.2021.03.010
  1. 28.Bhaskar Vaishnav, Nair Aathira Sujathan, Pappachen Leena K., 2023, , , (), 127, 10.1016/B978-0-323-98827-8.00006-0
  1. 29.Andritoiu Calin Vasile, Andriescu Corina Elena, Danu Maricel, Lungu Cristina, Ivanescu Bianca, et al, 2021, Evaluation of the Wound Healing Potential of Some Natural Polymers on Three Experimental Models, Pharmaceuticals, 14(5), 465, 10.3390/ph14050465
  1. 30.Deniz Dalgic Ali, Atila Deniz, Tezcaner Aysen, Gürses Senih, Keskin Dilek, 2023, Diatom silica frustules-doped fibers for controlled release of melatonin for bone regeneration, European Polymer Journal, 186(), 111858, 10.1016/j.eurpolymj.2023.111858
  1. 31.Lee Jin Sil, Oh Hyeryeon, Kim Sunghyun, Lee Jeung-Hoon, Shin Yong Chul, et al, 2021, A Novel Chitosan Nanosponge as a Vehicle for Transepidermal Drug Delivery, Pharmaceutics, 13(9), 1329, 10.3390/pharmaceutics13091329
  1. 32.Vivcharenko Vladyslav, Wojcik Michal, Palka Krzysztof, Przekora Agata, 2021, Highly Porous and Superabsorbent Biomaterial Made of Marine-Derived Polysaccharides and Ascorbic Acid as an Optimal Dressing for Exuding Wound Management, Materials, 14(5), 1211, 10.3390/ma14051211
  1. 33.Svensson Sofie E., Abdollahi Mehdi, Moghadam Farshad Homayouni, Kalita Naba Kumar, Hakkarainen Minna, et al, 2024, Valorization of Bread Waste to Fungal-Based Products for Medical Textile and Food Applications, ACS Sustainable Resource Management, 1(3), 385, 10.1021/acssusresmgt.3c00021
  1. 34.Ahmad Ruzaidi Dania Adila, Mahat Mohd Muzamir, Shafiee Saiful Arifin, Mohamed Sofian Zarif, Mohmad Sabere Awis Sukarni, et al, 2021, Advocating Electrically Conductive Scaffolds with Low Immunogenicity for Biomedical Applications: A Review, Polymers, 13(19), 3395, 10.3390/polym13193395
  1. 35.Chander Vikas, Singh Ajay K., Gangenahalli Gurudutta, 2018, Cell encapsulation potential of chitosan-alginate electrostatic complex in preventing natural killer and CD8+cell-mediated cytotoxicity: an in vitro experimental study, Journal of Microencapsulation, 35(6), 522, 10.1080/02652048.2018.1516827
  1. 36.Petkova Asya I., Kubajewska Ilona, Vaideanu Alexandra, Schätzlein Andreas G., Uchegbu Ijeoma F., 2022, Gene Targeting to the Cerebral Cortex Following Intranasal Administration of Polyplexes, Pharmaceutics, 14(6), 1136, 10.3390/pharmaceutics14061136
  1. 37.Yu Yang, Tang Yinxiang, Liang Weiwen, Wang Yuanbin, Ouyang Yang, et al, 2024, Asymmetric porous composite hydrogel patch for microenvironment-adapted repair of contaminated abdominal wall defects, Engineered Regeneration, (), 10.1016/j.engreg.2024.03.004
  1. 38.Madruga Liszt Y. C., Balaban Rosangela C., Popat Ketul C., Kipper Matt J., 2021, Biocompatible Crosslinked Nanofibers of Poly(Vinyl Alcohol)/Carboxymethyl‐Kappa‐Carrageenan Produced by a Green Process, Macromolecular Bioscience, 21(1), 10.1002/mabi.202000292
  1. 39.Tsai Cheng-Han, Wang Peng-Yuan, Lin I-Chan, Huang Hu, Liu Guei-Sheung, et al, 2018, Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application, International Journal of Molecular Sciences, 19(9), 2830, 10.3390/ijms19092830
  1. 40.Cannavà Carmela, De Gaetano Federica, Stancanelli Rosanna, Venuti Valentina, Paladini Giuseppe, et al, 2022, Chitosan-Hyaluronan Nanoparticles for Vinblastine Sulfate Delivery: Characterization and Internalization Studies on K-562 Cells, Pharmaceutics, 14(5), 942, 10.3390/pharmaceutics14050942
  1. 41.Zhou Liming, Liu Nanbo, Feng Longbao, Zhao Mingyi, Wu Peng, et al, 2022, Multifunctional electrospun asymmetric wettable membrane containing black phosphorus/Rg1 for enhancing infected wound healing, Bioengineering & Translational Medicine, 7(2), 10.1002/btm2.10274
  1. 42.Schmid Bernd C., 2019, Chitosan-Gaze – eine neue Wunderwaffe bei der postpartalen Blutung?, Der Gynäkologe, 52(6), 425, 10.1007/s00129-019-4443-5
  1. 43.Omer Ahmed M., Ahmed Maha S., El-Subruiti Gehan M., Khalifa Randa E., Eltaweil Abdelazeem S., 2021, pH-Sensitive Alginate/Carboxymethyl Chitosan/Aminated Chitosan Microcapsules for Efficient Encapsulation and Delivery of Diclofenac Sodium, Pharmaceutics, 13(3), 338, 10.3390/pharmaceutics13030338
  1. 44.Aguanell Antonio, del Pozo María Luisa, Pérez-Martín Carlos, Pontes Gabriela, Bastida Agatha, et al, 2022, Chitosan sulfate-lysozyme hybrid hydrogels as platforms with fine-tuned degradability and sustained inherent antibiotic and antioxidant activities, Carbohydrate Polymers, 291(), 119611, 10.1016/j.carbpol.2022.119611
  1. 45.Tripathi Satyavrat, Singh Bhisham Narayan, Divakar Singh, Kumar Gaurav, Mallick Sarada Prasanna, et al, 2021, Retracted: Design and evaluation of ciprofloxacin loaded collagen chitosan oxygenating scaffold for skin tissue engineering, Biomedical Materials, 16(2), 025021, 10.1088/1748-605X/abd1b8
  1. 46.Li Shuxin, Zhou Jun, Huang YiHui, Roy Joyita, Zhou Ning, et al, 2020, Injectable Click Chemistry-based Bioadhesives for Accelerated Wound Closure, Acta Biomaterialia, 110(), 95, 10.1016/j.actbio.2020.04.004
  1. 47.Abbas Tariq O, Parangusan Hemalatha, Yalcin Huseyin C, Hassan Mohamed, Zakrif Lubna, et al, 2024, Trilayer composite scaffold for urethral reconstruction: in vitro evaluation of mechanical, biological, and angiogenic properties, Biomedical Materials, 19(2), 025022, 10.1088/1748-605X/ad1c9c
  1. 48.Akhtar Muhammad Asim, Hadzhieva Zoya, Dlouhy Ivo, Boccaccini Aldo R., 2020, Electrophoretic Deposition and Characterization of Functional Coatings Based on an Antibacterial Gallium (III)-Chitosan Complex, Coatings, 10(5), 483, 10.3390/coatings10050483
  1. 49.Bharadwaj Tanmay, Chrungoo Shreya, Verma Devendra, 2023, Development of a novel thermogelling PEC-based ECM mimicking nanocomposite bioink for bone tissue engineering, Journal of Biomaterials Science, Polymer Edition, 34(18), 2516, 10.1080/09205063.2023.2265143
  1. 50.Kouser Sabia, Sheik Sareen, Nagaraja G.K., Prabhu Ashwini, Prashantha Kalappa, et al, 2020, Functionalization of halloysite nanotube with chitosan reinforced poly (vinyl alcohol) nanocomposites for potential biomedical applications, International Journal of Biological Macromolecules, 165(), 1079, 10.1016/j.ijbiomac.2020.09.188
  1. 51.Cabral Cátia S.D., de Melo-Diogo Duarte, Ferreira Paula, Moreira André F., Correia Ilídio J., 2024, Reduced graphene oxide–reinforced tricalcium phosphate/gelatin/chitosan light-responsive scaffolds for application in bone regeneration, International Journal of Biological Macromolecules, 259(), 129210, 10.1016/j.ijbiomac.2024.129210
  1. 52.Abu-Sbeih Khaleel A., Al-Mazaideh Ghassab M., Al-Zereini Wael A., 2022, Production of medium-sized chitosan oligomers using molecular sieves and their antibacterial activity, Carbohydrate Polymers, 295(), 119889, 10.1016/j.carbpol.2022.119889
  1. 53.Kumara B.N., Shambhu R., Prabhu Ashwini, Prasad K. Sudhakara, 2022, Novel chitosan - graphene quantum dots composite for therapeutic delivery and tracking through enzymatic stimuli response, Carbohydrate Polymers, 289(), 119426, 10.1016/j.carbpol.2022.119426